3 FTSE 100 Shares To Avoid Market Madness: AstraZeneca plc, SSE PLC And G4S plc

Statistically, AstraZeneca plc (LON:AZN), SSE PLC (LON:SSE) and G4S plc (LON:GFS) have all avoided wild market swings. Are the shares worth picking up?

| More on:

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.


Pharmaceuticals like AstraZeneca (LSE: AZN) (NYSE: AZN.US) are frequently steady performers. That is because their sales are rarely influenced by wider economic conditions.

AstraZeneca uses the relative safety of its income stream to pay a large dividend. As such, the company is regarded as one of the best income stocks on the market today.

However, earnings at AstraZeneca have been falling in recent years. Analysts have expressed some concerns over the company’s ability to develop new drugs and treatments.

A 5% earnings fall is forecast for 2013, with a 6% dip expected in 2014.

That puts the shares on a 2014 price-to-earnings (P/E) ratio of 10.1, with an anticipated yield of 5.7%. That’s a significant valuation discount to the average FTSE 100 share.


Utilities have even better visibility of future sales than the pharmaceuticals. The result is that their shares tend to avoid market extremes.

A large, dependable dividend also helps.

In the last five years, SSE (LSE: SSE) has increased its payout every year at an average rate of 6.8%. A dividend of 87.6p is forecast for 2013, rising to 91.5p next year.

At today’s price, that’s a forecast yield of 5.4%, rising to 5.6% in 2014.

Earnings are expected to increase even faster. That puts the shares on a 2013 P/E of 14, falling to 13 next year.

The shares are 15% ahead this year, suggesting that any future rises may be limited.


Outsourcing contractor G4S (LSE: GFS) is one of the most interesting opportunities in the FTSE 100 today.

Before the company’s failure to provide security guards for the London Olympics, G4S stock was loved by the investment community. After years of huge growth, the shares were frequently rated at a substantial premium to the rest of the market.

The Olympic fiasco, a profit warning in May and now a potential over-billing scandal has seen the shares lose fans fast. Today, G4S shares are trading on a 2013 P/E of 10.5, with an expected yield of 4.3%.

The G4S brand has taken a battering in the last year but if the company can win back the market’s love, then I expect the shares to rise significantly.

One of the world’s top investors has recently been backing G4S and AstraZeneca. Professional fund manager Neil Woodford has been beating the market for decades with his dividend income fund. For more of Mr Woodford’s top picks, get the free Motley Fool report “8 Shares Held By Britain’s Super Investor”. This report is totally free. Click here to get your copy today.

> David does not own shares in any of the companies mentioned.

Should you invest, the value of your investment may rise or fall and your capital is at risk. Before investing, your individual circumstances should be assessed. Consider taking independent financial advice.

More on Investing Articles

Mature black couple enjoying shopping together in UK high street
Investing Articles

How much must I invest in Tesco shares to earn income of £1,000 a year in 2024?

Tesco shares have given investors a winning combination of dividend income and share price growth lately. Should I buy them?

Read more »

Portrait of elderly man wearing white denim shirt and glasses looking up with hand on chin. Thoughtful senior entrepreneur, studio shot against grey background.
Investing Articles

Should I sell underperforming Fundsmith Equity or can Terry Smith beat the world again?

Terry Smith's investment vehicle Fundsmith Equity is heading for a second year of underperformance. Is it time to bail out?

Read more »

Shot of a young Black woman doing some paperwork in a modern office
Investing Articles

2 quality growth stocks I’m looking to buy in December

Stephen Wright thinks two growth stocks could be great investments for 2024. One is a FTSE 100 conglomerate, the other…

Read more »

Young Caucasian man making doubtful face at camera
Investing Articles

Does today’s beaten down Scottish Mortgage share price make it a no-brainer buy?

The crashing Scottish Mortgage share price has marred many a portfolio. Now there's talk of a recovery. Am I in?

Read more »

Young Caucasian woman with pink her studying from her laptop screen
Investing Articles

If I could only buy 1 more FTSE income stock in December, I’d grab this ultra-high-yielder

I think I can afford to buy one more FTSE 100 income stock before the end of the year. My…

Read more »

Abstract 3d arrows with rocket
Investing Articles

I think these are my best growth shares to buy with £1,000

Jon Smith talks through some shares to buy that he likes for next year, with a particular focus on retail…

Read more »

Young Asian man drinking coffee at home and looking at his phone
Investing Articles

2 terrific cheap shares I’d snap up before it’s too late!

Our writer wants to capitalise on cheap shares now before any potential market rally and identifies a couple of stocks…

Read more »

Mindful young woman breathing out with closed eyes, calming down in stressful situation, working on computer in modern kitchen.
Investing Articles

While the US stock market booms, the FTSE 100 lags behind. Or does it?

In November, global stock markets had their best month in over three years. Meanwhile, the UK's Footsie keeps falling further…

Read more »